Genetic control of catalepsy in mice

Genetic Predisposition to Disease

Volumn , Issue , 2008, Pages 215-236

  Kulikov, Alexander V ^a   Popova, Nina K ^a  

^a INSTITUTE OF CYTOLOGY AND GENETICS   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77954335850     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (104)

1. Abrams, R., Taylor, M.A. and Coleman-Stolurow, K. (1979). Catatonia and mania: patterns of cerebral dysfunction. Biol. Psychiatry, V.14. P.111-117.
2. Aghajanian, G.K. (1995). Electrophysiology of serotonin receptor subtypes and signal transduction pathways. In: Psychopharmacology: The Fourth Generation of Progress. Bloom, F.R. and Kupfer D.J.(eds.), Raven Press, New York, P.1451-1459.
3. Al-Khatib, I., Fujiwara, M. and Ueki, S. (1989) Relative importance of dopaminergic system in haloperidol-induced catalepsy and the anticataleptic effects of antidepressants and methamphetamine in rats. Pharmacol. Biochem. Behav., V.33. P.93-97.
4. Amir, S. Brown, Z.W., Amir, Z. and Ornstein, K. (1981). Body-pinches induced long lasting cataleptic-like immobility in mice: Behavioral characterization and the effects of naloxone. Life Sci., V.10. P.1189-1194.
5. Andersen, H.L. and Kilpatrick, I.C. (1996). Prevention by (+/-)-8-hydroxy-2-(di-npropylamino) tetralin of both catalepsy and the rises in rat striatal dopamine metabolism caused by haloperidol. Br. J. Pharmacol., V.118. P.421-427.
6. Barnes, N.M. and Sharp, T. (1999). A review of central 5-HT receptors and their function. Neuropharmacol., V.38. P.1083-1152.
7. Barykina, N.N., Chuguy, V.F., Alekhina, T.A., Kolpakov, V.G., Maksutova, A.V. and Kulikov, A.V. (2002). Effects of thyroid hormone deficiency on behavior in rat strains with different predisposition to catalepsy. Physiol. Behav., V.75. P.722-737.
8. Bazovkina, D.V., Kulikov, A.V., Kondaurova, E.M. and Popova N.K. (2005) Selection for predisposition to catalepsy enhances depressive-like traits in mice. Russ. J. Genet. V.41. P.1222-1228.
9. Benoff, F.H. and Siegel, P.B. (1976). Genetic analysis of tonic immobility in young Japanese quail (Coturnix coturnix japonica). Anim. Learning Behav., V.4. P.160-162.
10. Boulay, D., Depoortere, R., Oblin, A., Sanger, D.J., Schoemaker, H. and Perrault, G. (2000). Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice. Eur. J. Pharmacol., V.391. P.63-73.
11. Brewster, J. and Leon, M. (1980). Facilitation of maternal transport by Norway rat pups. J. Com. Physiol. Psychol., V.94. P.80-88.
12. Broekkamp, C.L., Oosterloo, S.K., Berendsen, H.H. and van Delf, A.M. (1988). Effect of metergoline, fenfluramine and 8-OH-DPAT on catalepsy induced by haloperidol or morphine. Naunyn-Schmiedebergerg's Arch. Pharmacol., V.338. P.191-195.
13. Casey, D.E. and Keepers, G.A. (1988). Neuroleptic side effects: acute extrapyramidal syndromes and tardive dyskinesia. Psychopharmacol Ser., V.5. P.74-93.
14. Chesnokova, V. and Melmed, S. (2002). Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology, V.143. P.1571-1574.
15. Cryan, J.F. and Mombereau, C. (2004). In search of a depressive mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry, V.9. P.326-357.
16. Danielson, P.E., Watson, J.B., Gerendasy, D.D., Erlander, M.G., Lovenberg, T.W., de Lecea, L., Sutcliffe, J.G. and Frankel, W.N. (1994). Chromosomal mapping of mouse genes expressed selectively within the central nervous system. Genomics, V.19. P.454-461.
17. 2 dopamine receptors. J. Pharmacol. Exp. Ther., V.285. P.1187-1196.
18. Derry, J.M., Lan, N.C., Shih, J.C., Barnard, E.A. and Barnard, P.J. (1989). Localization of monoamine oxidase A and B genes on the mouse X chromosome. Nucleic Acids Res., V.17. P.8403.
19. Dixon, A.K. (1998). Ethological strategies for defense in animals and humans: Their role in some psychiatric disorders. Br. J. Med. Psychol. V.71. P.417-445.
20. Dunn, A.J. (2006). Effects of cytokines and infections on brain neurochemistry. Clin. Neurosci. Res., V.6. P.52-68.
21. Duvoisin, R.C. (1976). Parkinsonism: Animal analogues of human movement disorder. In: The Basal Ganglia, Yahr, M.D. (ed.), Raven Press, New York, P.293-303.
22. Elliott, P.J., Walsh, D.M., Close, S.P., Higgins, G.A. and Hayes, A.G. (1990). Behavioural effects of serotonin agonists and antagonists in the rat and marmoset. Neuropharmacology, V.29. P.949-956.
23. Erskine, M.S., Barfield, R.J. and Goldman, B.D. (1980). Postpartum aggression in rats. II. Dependence on maternal sensitivity to young and effects of experience with pregnancy and parturition. J. Comp. Physiol. Psychol., V.94. P.495-505.
24. Gallup, G.G. (1974). Genetic influence on tonic immobility in chickens. Anim. Learning Behav., V.2. P.145-147.
25. Gallup, G.G. (1977). Tonic immobility: The role of fear and predation. Psychol. Res., 1977. V.27. P.41-61.
26. Gallup, G.G., Boren, J.L., Suares, S.D. and Wallnau, L.B. (1983). The psychopharmacology of tonic immobility in chickens. In: The brain and behavior of the fowl, Ookawa, T. (ed.), Japan Sci. Soc. Press, Tokyo, P.43-59.
27. Garver, D.L. (1984). Disease of the nervous system: Psychiatric disorders. In: Clinical chemistry: Theory, analysis and correlations, Kaplan, L.A. and Pesce, A.J. (eds.), Mosby, St Louis, P.864-881.
28. Gregor, P., Patel, A., Shimada, S., Lin, C.L., Rochelle, J.M., Kitayama, S., Seldin, M.F. and Uhl, G.R. (1993). Murine serotonin transporter: sequence and localization to chromosome 11. Mammal. Genome, V.4. P.283-284.
29. Hicks, P.B. (1990). The effect of serotonergic agents on haloperidol-induced catalepsy. Life Sci., V.47. P.1609-1615.
30. Hitzemann, R., Dains, K., Bier-Langing, C.M. and Zahniser, N.R. (1991). On the selection of mice for haloperidol response and non-response. Psychopharmacol., V.103. P.244-250.
31. Hjorth, S., Bengtsson, H.J., Milano, S., Lundberg, J.F. and Sharp, T. (1995). Studies on the role of 5-HT1A autoreceptors and alpha1-adrenoreceptors in the inhibition of 5-HT release I. BMY7378 and prazosin. Neuropharmacol., V.34. P.615-620.
32. Hsieh, C.L., Bowckock, A.M., Farrer, L.A., Hebert, J.M., Huang, K.M., Cavalli-Sforza, L.L., Julius, D. and Francke, U. (1990). The serotonin receptor subtype 2 locus HTR2 on human chromosome 13 near genes for esterase D and retinoblastoma-1 and on mouse chromosome 14. Somat. Cell. Mol. Genet., V.16. P.567-574.
33. Invernizzi, R.W., Cervo, L. and Samanin, R. (1988). 8-Hydroxy-2-(di-Npropylamino) tetralin, a selective serotonin1A receptor agonist, blocks haloperidolinduced catalepsy by an action on raphe nuclei medianus and dorsalis. Neuropharmacol., V.27. P.515-518.
34. Jacobs, B.L. and Azmitia, E.C. (1992). Structure and function of the brain serotonin system. Physiol. Rev., V.72, P.165-229.
35. Kanes, S., Dains, K., Cipp, L., Gatley, J., Hitzemann, B., Rasmussen, E., Sanderson, S., Silverman, M. and Hitzemann, R. (1996). Mapping the genes for haloperidol-induced catalepsy. J. Pharmacol. Exp. Ther., V.277. P.1016-1025.
36. 2 receptor density and neuroleptic-induced catalepsy among eight inbred strains of mice. J. Pharmacol. Exp. Ther., V.267. P.538-547.
37. Khisti, R., Mandhane, S. and Chopde, C. (1997). Haloperidol-induced catalepsy: a model for screening antidepressants effective in treatment of depression with Parkinson's disease. Indian J. Exp. Biol., V.35. P.1297-1301.
38. Klemm, W.R. (1989). Drug effects on active immobility responses: What they tell us about neurotransmitter systems and motor functions. Progress in Neurobiology, V.32. P.403-422.
39. Klemm, W.R. (1990). Behavioral inhibition. In: Brainstem Mechanisms of Behavior, Klemm, W.R. and Vertes, R.P. (eds.), John Wiley & Sons, New York, P.497-533.
40. Kolpakov, V.G., Barykina, N.N. and Chepkasov, I. (1981). Genetic predisposition to catatonic behaviour and methylphenidate sensitivity in rats. Behav. Proc., V.6. P.269-281.
41. Kolpakov, V., Barykina, N.N., Alekhina, T.A. and Chepkassov, I. (1985). Catalepsy in rats: Its inheritance and relationship to pendulum movements and audiogenic epilepsy. Behav. Proc., V.10. P.63-76.
42. Kondaurova, E.M., Kulikov, A.V., Bazovkina, D.V. and Popova, N.K. (2007). High predisposition to freezing decreases intermale aggression and increases acoustic startle reflex amplitude. Zh. Vyssh. Nervn. Deyat., V.57. P.501-507 (in Russian).
43. Kondaurova, E.M., Bazovkina, D.V., Kulikov, A.V. and Popova, N.K. (2006) Selective breeding for catalepsy changes the distribution of microsatellite D13Mit76 alleles linked to the 5-HT1A serotonin receptor gene in mice. Genes Brain Behav., V.5. P.596-6013.
44. Kostowski, W., Gumulka, W. and Czlonkowski, A. (1972). Reduced cataleptogenic effects of some neuroleptics in rats with lesioned midbrain raphe and treated with pchlorophenylalanine. Brain Res., V.48. P.443-446.
45. Kulikov, A., Avgustinovich, D.F., Kolpakov, V.G., Maslova, G.B. and Popova, N.K. (1995a). 5-HT2A serotonin receptors in the brain of rats and mice hereditary predisposed to catalepsy, Pharmacol. Biochem. Behav., V.50. V.383-387.
46. Kulikov, A.V., Barykina, N.N., Tikhonova, M.A., Chuguy, V.F., Kolpakov, V.G. and Popova, N.K. (2002). Effect of chronic thyroxine treatment on catalepsy in rats. Neurosci. Lett., V.330. P.207-209.
47. Kulikov, A.V. and Bazovkina, D.V. (2003). Testing linkage in hybrid analysis of alternatively distributed behavioral traits with incomplete penetrance. Rus. J. Genetics, V.39. P.1066-1072.
48. Kulikov, A.V., Bazovkina, D.V., Kondaurova, E.M., and Popova, N.K. (2008). Genetic structure of hereditary catalepsy in mice. Genes Brain. Behav., 7, 506-512.
49. Kulikov, A.V., Bazovkina, D.V., Moisan, M.P. and Mormede, P. (2003). The mapping of the gene of susceptibility to catalepsy in mice using polymorphic microsatellite markers. Dokl. Biol. Sci., V.393. V.531-534.
50. Kulikov, A., Karmanova, I., Kozlachkova, E., Voronova, I. and Popova, N. (1994a). The brain tryptophan hydroxylase activity in the sleep-like states in frog. Pharmacol. Biochem. Behav., V.49. P.277-279.
51. Kulikov, A., Kolpakov, V., Maslova, G., Kozintsev, I. and Popova, N. (1994b). Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats. Psychopharmacology, V.114. P.172-174.
52. Kulikov, A.V., Kolpakov, V.G., and Popova, N.K. (2006). The genetic cataleptic (GC) rat strain as a model of depressive disorders. In: Animal Models in Biological Psychiatry, Kaluev, A. (ed.), Nova Science Publishers, New York, P.59-73.
53. Kulikov, A., Kozlachkova, E., Kudryavtseva, N. and Popova, N. (1995b). Correlation between tryptophan hydroxylase activity in the brain and predisposition to pinch-induced catalepsy in mice. Pharmacol. Biochem. Behav., V.50. P.431-435.
54. Kulikov, A.V., Kozlachkova, E.Y., Maslova, G.B. and Popova, N.K. (1993). Inheritance of predisposition to catalepsy in mice. Behav. Genet., V.23. P.379-384.
55. Kulikov, A.V., Kozlachkova, E.Y. and Popova, N. K. (1989). The genetic control of catalepsy in mice. Rus. J. Genet., V.25. P.1402-1408.
56. Kulikov, A.V., Kozlachkova, E.Y. and Popova, N.K. (1992). The activity of tryptophan hydroxylase in brain of hereditary predisposed to catalepsy rats. Pharmacol. Biochem. Behav., V.43. P.999-1003.
57. Kulikov, A.V., Tikhonova, M.A., Chugui, V.F., Alekhina, T.A., Kolpakov, V.G., and Popova, N.K. (2004). Chronic administration of imipramine decreases freezing time in rats genetically predisposed to catalepsy. Bull. Exp. Biol. Med., V.138. P.401-403.
58. Lesch, K.P. (1997). Molecular biology, pharmacology, and genetics of the serotonin transporter: psychobiological and clinical implications. In: Serotonergic Neurons and 5-HT Receptors in the CNS, Baumgarten, H.G. and Gothert, M. (eds.), Springer, New York, P.671-705.
59. Liu, Y.F., Chen, Y., Kozak,C.A. and Yu, L. (1991). The 5-HT2 serotonin receptor gene Htr-2 is tightly linked to Es-10 on mouse chromosome 14. Genomics, V.11. P.231-234.
60. Neal-Beliveau, B.S., Joyce, J.N. and Lucki, I. (1993). Serotonergetic involvement in haloperidol-induced catalepsy. J. Pharmacol. Exp. Therap., V.265. P.207-217.
61. Oakey, R.J., Caron, M.G., Lefkowitz, R.J. and Seldin, M.F. (1991). Genomic organization of adrenergic and serotonin receptors in the mouse: Linkage mapping of sequece-related genes provides a method for examining mammalian chromosome evolution. Genomics, V.10. P.338-344.
62. Onodera, K. (1991). Effects of antidepressants and antihistaminics on catalepsy induced by intracerebtoventricular administration of histamine in mice. Methods Find. Exp. Clin. Pharmacol., V.13. P.397-403.
63. Ornstein, K. and Amir, S. (1981). Pinch-induced catalepsy in mice. J. Comp. Physiol. Psychol., V.95. P.827-835.
64. 2 dopamine receptors in neuroleptic catalepsy. Eur. J. Pharmacol., V.182. P.327-334.
65. Patel, N. and Hitzemann, R. (1999). Detection and mapping of QTL for haloperidol-induced catalepsy in C57BL/6J and DBA/2J F2 Intercross. Behav. Genet., V.29. P.303-310.
66. Popova, N.K., Augustinovich, D.F., Kolpakov, V.G. and Plyusnina, I.Z. (1998). Specific [3H]8-OH-DPAT binding in brain regions of rats genetically predisposed to various defense behavior strategies. Pharmacol. Biochem. Behav., V.59. P.793-797.
67. Popova, N.K., Augustinovich, D.F., Shigantsov, S.N. and Kulikov, A.V. (1996). Serotonin 5-HT1A receptors in brain regions of genetically predisposed to catalepsy rats. Zh. Vyssh. Nervn. Deyat., V.46. P.578-582.
68. Popova, N. and Kulikov, A. (1995). On the role of brain serotonin in expression of genetic predisposition to catalepsy in animal models. Am. J. Med. Genetics (Neuropsychiatric Genetics), V.60. P.214-220.
69. Popova, N.K., Kulikov, A.V., Avgustinovich, D.F., Vishnivetskaya, G.B. and Kolpakov, V.G. (1994). Influence of brain 5-HT1A serotonin receptors in the regulation of inherited catalepsy. Bull. Exp. Biol. Med., V.118. P.633-635 (in Russian).
70. Popova, N.K., Lobacheva, I.L., Karmanova, I.G. and Shilling, N.V. (1984). Serotonin in the control of the sleep-like states in frogs. Pharmacol. Biochem. Behav., V.20. P.53-57.
71. Prinssen, E.P., Colpaert, F.C. and Koek, W. (2002). 5-HT1A receptor activation and anticataleptic effects: high-efficacy agonists maximally inhibit haloperidol-induced catalepsy. Eur. J. Pharmacol., V.453. P.217-221.
72. Prinssen, E.P., Koek, W., Colpaert, F.C. and Kleven, M.S. (2000). Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy. Behav. Pharmacol., V.11. P.299-305.
73. 2 dopamine receptors. Mol. Pharmacol., V.48. P.730-737.
74. Rasmussen, E., Cipp, L. and Hitzemann, R. (1999). Identification of quantitative trait loci for haloperidol-induced catalepsy on mouse chromosome 14. J. Pharmacol. Exp. Ther., V.290. P.1337-1346.
75. Robinson, V.J. and Coob, M.Y. (1997). Mitogen-activated protein kinase pathways. Curr. Opin. Cell. Biol., V.9. P.180-186.
76. Sanberg, P.R., Bunsey, M.D., Giordano, M. and Norman, A.B. (1988). The catalepsy test: Its ups and downs. Behav. Neurosci., V.102. P.748-759.
77. Sanberg, P.R. and Coyle, J.T. (1984). Scientific approaches to Hantington's disease. CRC Critical Review in Clinical Neurobiology, V.1. P.1-44.
78. Sanders-Bush, E. and Canton, H. (1995). Serotonin receptors. Signal transduction pathways. In: Psychopharmacology: The Fourth Generation of Progress, Bloom, F.E. and Kupfer, D.J. (eds.), Raven Press, New York, P.431-441.
79. Saudou, F. and Hen, R. (1994). 5-Hydroxytryptamine receptor subtypes: Molecular and functional diversity. Adv. In Pharmacol., V.30. P.327-380.
80. Sharp, T. and Hjorth, S. (1990). Application of brain microdialysis to study the pharmacology of the 5-HT1A autoreceptor. J. Neurosci. Methods, V.34. P.83-90.
81. Sharp, T., Umbers, V. and Hjorth, S. (1996). The role of 5-HT1A autoreceptors and alpha1-adrenoreceptors in the inhibition of 5-HT release. II. NAN-190 and SDZ 216-525. Neuropharmacol., V.35. P.735-741.
82. Simon-Chazettes, D., Cloez-Tayarani, I., Fillion, M.P., Guenet, J.L. and Fillion, G. (1993). The serotonin 5-HT1B receptor subtype (HTr1b) gene maps to mouse chromosome 9. Mammal. Genome, V.4. P.397-398.
83. Singerman, B. and Raheja, R (1994). Malignant catatonia-a continuing reality. Ann. Clin. Psychiatry, V.6. P.259-266.
84. Skrinskaya, Y. A., Nikulina, E.M. and Popova, N.K. (1992). Role of genotype in the cataleptogenic effect of neuroleptics. Exp. Clin. Pharmacol., V.55. P.7-9.
85. Stoll, J., Kozak, C. and Goldman, D. (1990). Characterization and chromosomal mapping of a cDNA encoding thryptophan hydroxylase from a mouse mastocytoma cell line. Genomics, V.7. P.88-96.
86. Suglyama, Y., Suzuki, A., Kishikawa, M., Akutsu, R., Hirose, T., Waye, M. M. Y., Tsui, S. K.W., Yoshida, S. and Phno, S. (2000). Muscle develops a specific form of small heat shock protein complex composed of MKBP/HSPB2 and HSPB3 during myogenic differentiation. J. Biol. Chem., V.275. P.1095-1104.
87. Sundaresan, S., Yang-Feng, T.L. and Francke, U. (1989). Genes for HMG-CoA reductase and serotonin 1a receptor are on mouse chromosome 13. Somat. Cell. Mol. Genet., V.15. P.465-469.
88. Tecott, L.H. (2003). The genes and brains of mice and men. Am. J. Psychiatry, V.160. P.646-656.
89. Tikhonova, M.A., Lebedeva, V.V., Kulikov, A.V., Bazovkina, D.V. and Popova, N.K. (2006). Effect of imipramine on the behavior and cerebral 5-HT1A serotonin receptors in mice genetically predisposed to catalepsy. Bull. Exp. Biol. Med., V.141. P.48-50.
90. Wadenberg, M.L. (1996). Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat. Neurosci Biobehav Rev., V.20. P.325-339.
91. Wadenberg, M.L. and Ahlenius, S. (1995). Antagonism by the 5-HT2A/C receptor agonist DOI of raclopride-induced catalepsy in the rat. Eur. J. Pharmacol., V.294. P.247-251.
92. 2 receptor mechanisms in the mediation of extrapyramidal motor functions in the rat. Pharmacol. Biochem. Behav., V.47. P.509-513.
93. Wadenberg, M.L., Hillegaart, V. and Berge, O.G. (1993). Supraspinal mediation of dopamine-serotonin interactions in extrapyramidal motor functions in the rat. NeuroReport, V.4. P.59-61.
94. Waggoner, D.W., Xu, J., Singh, I., Jasinska, R., Zhang, Q.X. and Brindley, D.N. (1999). Structural organization of mammalian lipid phosphate phosphatases: implications for signal transduction. Biochim. Biophys. Acta, V.1439. P.299-316.
95. Walther, D. and Bader, M. (2003). A unique central tryptophan hydroxylase isoform. Bioche. Pharmacol., V.66. P.1673-1680.
96. Walther, D.J., Peter, J.-U., Bashammakh, S., Hortnagl, H., Voits, M., Fink, H. and Bader, M. (2003). Synthesis of serotonin by a second thryptophan hydroxylase isoform. Science, V.299. P.76.
97. 2 long receptor-deficient mice display alterations in striatum-dependent functions. J. Neurosci., V.20. P.8305-8314.
98. Weydert, A., Cloez-Tayarani, I., Fillion, M.P., Simon-Chazottes, D., Guenet, J.L. and Fillion, G. (1992). Molecular cloning the partial serotonin 5-HT1D receptor sequences in mouse and one in guinea pig. C.R. Acad. Sci. III, V.314. P.429-435.
99. Wu, Y., Shaghaghi, E.K., Jacquot, C., Pallardy, M. and Gardier, A.M. (1999). Synergism between interleukin-6 and interleukin-1β in hypothalamic serotonin release: a reverse in vivo microdialysis study in F344 rats. Eur. Cytokine Netw., V.10. P.57-64.
100. Yu, L., Nguyen, H., Le, H., Bloem, L.J., Kozak, C.A., Hoffman, B.J., Soutch, T.P., Lester, H.A., Davidson, N. and Lubbert, H. (1991). The mouse 5-HT1C receptor contains eight hydrophobic domains and is X-linked. Mol. Brain. Res., V.11. P.143-149.
101. Zhang, J.-J., Terreni, L., De Simoni, M.-G. and Dunn, A.J. (2001). Peripheral interleukin-6 administration increases extracelluler concentration of serotonin and the evoked release of serotonin in the rat striatum. Neurochem. Int., V.38. P.303-308.
102. 2 receptors: behavioral correlates. Neurosci. Lett., V.161. P.223-226.
103. Zhang, X., Beaulieu, J.M., Sotnikova, T.D., Gainetdinov, R.R. and Caron, M.G. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science, V.305. P.217.
104. Zhao, T., Zhang, H., Guo, Y. and Fan, Z. (2007). Granzyme K directly processes bid to release cytochrome c and endonuclease G leading to mitochondria-dependent cell death. J. Biol. Chem., V.282. P.12104-12111.